The Pharmacy Times® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to specialty pharmacists.
January 30th 2025
Meloxicam and rizatriptan reduces migraine pain and help patients return to normal functioning with efficacy through 24 to 48 hours after a single dose for some patients.
Novo Nordisk Introduces HemaGo, a Mobile Application for Hemophilia
November 30th 2012Novo Nordisk announced the introduction of HemaGo, a mobile application (app) to help individuals with hemophilia and their caregivers monitor the details of treatment, including medications, dosing, bleed information and the impact of hemophilia on life events.
Read More
Medicare Could Have Saved $33 Million on Prostate Cancer Drugs
November 28th 2012By prescribing clinically similar luteinizing hormone–releasing hormone agonists for the treatment of prostate cancer, Medicare could have saved 13% of its total budget for monthly injections, according to a study from the Office of the Inspector General.
Read More
Specialty Pharmacy Services Produce Better Health Outcomes for RA Patients
November 28th 2012In a retrospective analysis, researchers concluded that rheumatoid arthritis patients had better outcomes when they filled their prescriptions through a mail-order specialty pharmacy rather than a retail pharmacy.
Read More
Specialty Products: BriovaRx's Holistic Approach
November 28th 2012In an exclusive interview with Specialty Pharmacy Times, Albert Thigpen, Senior Vice President of Pharmacy Operations & Industry Relations at Catamaran Corporation, spoke about his distinct responsibilities surrounding the management of pharmaceutical manufacturers, Catamaran's 3 mail order pharmacies, and BriovaRx's 11 specialty pharmacies.
Read More
Higher Copays for Multiple Sclerosis Medications Contribute to Poor Patient Compliance, Outcomes
November 22nd 2012A recent study featured in the American Journal of Pharmacy Benefits examines the role of patient out-of-pocket cost on adherence to disease-modifying therapies for multiple sclerosis.
Read More
Xeljanz: Juggling a Delicate Risk-Benefit Ratio
November 16th 2012Pfizer's Xeljanz (tofacitinib) is the first Janus kinase inhibitor approved for rheumatoid arthritis and the first oral biologic within the RA class. Dina Rufo of GlobalData discusses the factors that will affect uptake of the drug.
Read More
CSPN Signs Distribution Agreement with Dara BioSciences
November 16th 2012Community Specialty Pharmacy Network, Inc (CSPN), recently announced a distribution agreement with Dara BioSciences for Soltamox (tamoxifen citrate), a nonsteroidal antiestrogen for the treatment of patients with breast cancer.
Read More
Diplomat Specialty Pharmacy Announces Executive Hire and Promotion
November 16th 2012Diplomat Specialty Pharmacy announced that Jennifer Cretu has been promoted to vice president of information technology and pharmacy executive Thomas Michaels has joined the company as vice president of sales and marketing.
Read More
UnitedHealthcare Bars Copay Coupons for Specialty Drugs
November 14th 2012According to a report by Elsevier's Business Intelligence, UnitedHealthcare has announced that pharmacies that are participating in its Designated Specialty Pharmacy network will no longer redeem manufacturer-sponsored coupons.
Read More
Sanofi Halves the Price of Zaltrap in Response to Criticism from Oncologists
November 13th 2012Sanofi slashed the price of colorectal cancer drug Zaltrap (ziv-aflibercept) in half after 2 oncologists from Memorial Sloan-Kettering Cancer Center publicly balked at the drug's $11,000 price tag in an op-ed in The New York Times.
Read More
Diplomat Specialty Pharmacy Hiring Continues as Long-Term Michigan Growth Plan Moves Forward
November 7th 2012Diplomat Specialty Pharmacy, the nation's largest privately held specialty pharmacy company servicing the needs of patients and physicians nationwide, is on target to meet its long-term growth plan with the announcement that it has an immediate need to fill 100 full-time jobs.
Read More
Cardinal Health Specialty Pharmacy, OncoSourceRx, Earns URAC Accreditation
November 1st 2012Cardinal Health Specialty Solutions announced today that its specialty pharmacy, OncoSourceRx, has been awarded Specialty Pharmacy Accreditation from URAC, a Washington, DC-based health care accrediting organization that establishes quality standards for the health care industry.
Read More
Avella Specialty Pharmacy to Distribute Soltamox
October 22nd 2012Avella Specialty Pharmacy, under an agreement with DARA BioSciences, Inc, will be a distribution source for Soltamox, the first and only FDA-approved oral liquid formulation of tamoxifen citrate for the prevention and treatment of breast cancer.
Read More
Former FDA Chief Comments on the Drug Approval Process
October 19th 2012In this Medscape One-on-One video, former FDA Commissioner and former director of the National Cancer Institute Andrew von Eschenbach, MD, suggests using adaptive trial design to test drugs rather than a stepwise approach.
Read More
The Specialty Pharmacy Pipeline: What's Next?
October 17th 2012In a session at the 2012 Academy of Managed Care Pharmacy Educational Conference, Aimee Tharaldson, PharmD, identified the top specialty drugs in the pipeline and highlighted the most recent therapeutic trends within each medication class.
Read More
Multiple Sclerosis Drug Costs Account for More Than Two-Thirds of Patients' Total Cost of Care
October 17th 2012A new study carried out by Blue Cross and Blue Shield of Minnesota and PBM Prime Therapeutics forecasts that multiple sclerosis specialty drug treatment cost will exceed $50,000 per person per year in 2016.
Read More